Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
Science1995Vol. 267(5196), pp. 381–383
Citations Over TimeTop 1% of 1995 papers
Massimo Santoro, Francesca Carlomagno, Alfredo Romano, Donald P. Bottaro, Nina Dathan, Michèle Grieco, Alfredo Fusco, Giancarlo Vecchio, Brona Matoskova, Matthias H. Kraus, Pier Paolo Di Fiore
Abstract
Multiple endocrine neoplasia types 2A and 2B (MEN2A and MEN2B) and familial medullary thyroid carcinoma are dominantly inherited cancer syndromes. All three syndromes are associated with mutations in RET, which encodes a receptor-like tyrosine kinase. The altered RET alleles were shown to be transforming genes in NIH 3T3 cells as a consequence of constitutive activation of the RET kinase. The MEN2A mutation resulted in RET dimerization at steady state, whereas the MEN2B mutation altered RET catalytic properties both quantitatively and qualitatively. Oncogenic conversion of RET in these neoplastic syndromes establishes germline transmission of dominant transforming genes in human cancer.
Related Papers
- → Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan(1996)502 cited
- → Differences between germline and somatic mutation rates in humans and mice(2017)431 cited
- → The mutational landscape of human somatic and germline cells(2022)13 cited
- → Germline mutations in the Von Hippel‐Lindau disease (VHL) gene in families from North America, Europe, and Japan(1996)42 cited
- → 28. Identification of TP53 germline variants in pediatric patients undergoing tumor testing(2022)